Literature DB >> 27800636

Diagnostic value of autoantibodies combined detection for rheumatoid arthritis.

Pingping Sun1, Wanhai Wang1, Ling Chen2, Nan Li1, Xianchun Meng1, Jing Bian1, Jingjing Yang1, Xu'na Wang1, Weitao Zhu1, Liang Ming1.   

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is a chronic, inflammatory and autoimmune disease, there are many autoantibodies produced during disease progression in the patients' serum, and this work is to select a best detection scheme for RA diagnosis.
METHODS: Autoantibody levels including rheumatoid factor (RF), anti-cyclic citrullinated peptide (CCP), mutated citrullinated vimentin (MCV), anti-keratin antibodies(AKA), anti-perinuclear factor (APF), and Ig heavy chain binding protein (BIP), were measured, and the sensitivity, specificity, predictive values, accuracy, and Youden's index of different combining forms were all calculated in RA patients, disease, and healthy control group. The differences in the positive rates of the three groups were compared between any two of them.
RESULTS: Generally speaking, the sensitivity of the autoantibodies detected in parallel combination was higher than that in tandem, which was more specific. The sensitivity of anti-MCV and RF calculated in parallel (87.61%) was obviously better than that of anyone autoantibody (P<.05), and only increased slightly even if more autoantibodies were tested in parallel (P>.05). The specificity of anti-CCP and BIP measured in tandem (95.92%) was obviously higher than that of anyone autoantibody (P<.05). While increasing the detected number of autoantibody from two kinds to three or more, the specificity was improved insignificantly (P>.05).
CONCLUSION: Anti-BIP and CCP antibodies detected in tandem combination can obtain higher specificity, and have good clinical value for the differential diagnosis of RA.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  anti-cyclic citrullinated peptide; binding protein; mutated citrullinated vimentin; rheumatoid arthritis; rheumatoid factor

Mesh:

Substances:

Year:  2016        PMID: 27800636      PMCID: PMC6816999          DOI: 10.1002/jcla.22086

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

Review 1.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

2.  The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis.

Authors:  V M Corrigall; M D Bodman-Smith; M S Fife; B Canas; L K Myers; P Wooley; C Soh; N A Staines; D J Pappin; S E Berlo; W van Eden; R van Der Zee; J S Lanchbury; G S Panayi
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 3.  The epidemiology of rheumatoid arthritis.

Authors:  S E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2001-05       Impact factor: 2.670

4.  Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.

Authors:  Emilio Besada; Cathrin Nikolaisen; Hans Nossent
Journal:  Clin Exp Rheumatol       Date:  2011-02-23       Impact factor: 4.473

Review 5.  Rheumatoid arthritis.

Authors:  D M Lee; M E Weinblatt
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

6.  Anti-keratin antibodies in patients with rheumatoid arthritis.

Authors:  B L Sharma; R Rani; R Misra; A Aggarwal
Journal:  Indian J Med Res       Date:  2000-06       Impact factor: 2.375

7.  Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.

Authors:  J Vencovský; S Machácek; L Sedová; J Kafková; J Gatterová; V Pesáková; S Růzicková
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

8.  Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.

Authors:  Rim Sghiri; Elyes Bouajina; Dhaker Bargaoui; Latifa Harzallah; Hosni Ben Fredj; Samar Sammoud; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

9.  Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study.

Authors:  Lílian Santuza Santos Porto; Wilson Campos Tavares Júnior; Dário Alves da Silva Costa; Cristina Costa Duarte Lanna; Adriana Maria Kakehasi
Journal:  Rev Bras Reumatol       Date:  2015-09-14

10.  Novel 68 kDa autoantigen detected by rheumatoid arthritis specific antibodies.

Authors:  S Bläss; C Specker; H J Lakomek; E M Schneider; M Schwochau
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

View more
  6 in total

1.  Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis.

Authors:  Xue-Ping Wang; Qian-Yao Cheng; Ming-Ming Gu; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2019-02-27       Impact factor: 2.980

2.  The diagnostic utility of rheumatoid factor and anticitrullinated protein antibody for rheumatoid arthritis in the Indian population.

Authors:  Abhishek Kumar; Vivek Vasdev; Saroj Kumar Patnaik; Satyam Bhatt; Ramakant Singh; Aprajita Bhayana; Arun Hegde; Ashwani Kumar
Journal:  Med J Armed Forces India       Date:  2020-07-17

3.  Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.

Authors:  Pieter W A Meyer; Mahmood T M Ally; Bridget Hodkinson; Ronald Anderson; Mohammed Tikly
Journal:  Rheumatol Int       Date:  2018-04-30       Impact factor: 2.631

4.  Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy.

Authors:  Veerle Ide; Xavier Bossuyt; Daniël Blockmans; Ellen De Langhe
Journal:  RMD Open       Date:  2018-07-25

5.  Analysis of Risk Factors for Rheumatoid Arthritis in Yunnan: A Small-Scale Case-Control Study.

Authors:  Wenrun Li; Yi Sun
Journal:  Comput Intell Neurosci       Date:  2022-06-23

Review 6.  Research progress on serological indices and their clinical application in rheumatoid arthritis.

Authors:  Shuting Meng; Longxiao Jing; Weiwei Zhang; Feng Wang; Yefeng Dong; Deping Dong
Journal:  J Clin Lab Anal       Date:  2022-07-15       Impact factor: 3.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.